Navigation Links
Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
Date:11/3/2008

WALTHAM, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI) announced today that Lewis H. Bender, Chief Executive Officer, will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008, at 11:35 am EST. The conference will be held at the New York Palace Hotel in New York.

A live audio webcast of the presentation will be available on the Events section of the Interleukin Genetics website, http://www.ilgenetics.com/content/about-interleukin/events.jsp. A replay of the presentation will be available on the Company's website for 14 days following the presentation.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics has developed and commercialized genetic tests for risk assessment of coronary artery disease, periodontal disease, and general nutrition. The Company currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers. Interleukin is headquarter
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Interleukin-12 indicates survival prospects for melanoma patients
2. LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
3. Interleukin Genetics Reports Fourth Quarter and Year End 2007 Financial Results
4. T cell immunity enhanced by timing of interleukin-7 therapy
5. Interleukin Genetics, Inc. Management to Present at Healthcare Conferences
6. Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7
7. DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results
8. Genetics, Environment Shape Sexual Behavior
9. Homosexual behavior due to genetics and environmental factors
10. 2008 Gruber Genetics Prize awarded to Allan Spradling of Carnegie Institution
11. 6 Nobel Prize Winners at International Congress of Genetics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Newswire-FirstCall/ - Hard To Treat Diseases (HTDS...ovartis, a US$41 billion international healthcare ...accine partner, Zhejiang Tianyuan Bio-Pharmaceutic...zerland will begin a five-year, $1 billion China i...ally increase its investment in its China R&D ...
(Date:11/9/2009)...w may be too late when it comes to preventing or i...lub, Inc. (Take Off Pounds Sensibly), the nonprofi... (Vocus) November 9, 2009 -- Tomorrow ...roving a diabetes condition, according to TOPS Clu...weight-loss support organization., , ,Diabetes is ...
(Date:11/9/2009)...dy highlights positive influence of sports partici...osemont, IL (Vocus) November 9, 2009 -- As people ...Recent research has highlighted the importance of ...hese issues. However, a new study published in the...idisciplinary Approach reveals that there may be ...
(Date:11/9/2009)...9 Actress Mariska Hargitay and the... on Saturday to raise awareness about the need for...ifornia by building healing and wellness kits for ...d to give one to each of the estimated 600 women c...,s domestic violence shelters. ,, "Our goal is ...
(Date:11/9/2009)... National Ambassador ,, WHITE PLAINS, N.Y., N... Weston, Fla., was born so early and with so many ...hether he would survive -- or if he would ever wal...med March of Dimes 2010 National Ambassador. ,...t minutes of motherhood and I was completely devas...
Breaking Medicine News(10 mins):Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3
...s,International, Inc. (NYSE: WTW ) will release i...YSE close on Thursday, July 31, 2008., The Compan...t at 5:00,p.m. ET. During the conference call, Dav...s from the investment community., Live audio of t...
...l Combat Veterans, WASHINGTON, July 9 Combat vet...er assistance in 39 additional,communities across ...rs,(VA) will develop Vet Centers by fall 2009., "...terans Affairs. "I,m pleased we can expand access ...
...pitals, WASHINGTON, July 9 CNN reported this mor... System (Corpus Christi TX),received overdoses of ...DT,one of the babies has died; another is in criti...Group,s number one,safety measure that it urges al...
... of new lines may be done without destroying embry...- Scientists say they have finally succeeded in de... development stage of a blastomere, or a 4-cell st...& Embryology annual conference in Barcelona, m...
...tion of 50 years of publishing groundbreaking rese...3 papers that highlight pivotal research and signi...rgonomics (HF/E). The entire online issue is avail...ystems, environments, tools, and products. As note...
...8 Led by Anna Catriona Phillips of the University...to a hepatitis A vaccine in young healthy adults a... vaccination in older community-based adults. , ...ession (10 am to 12 pm) or early evening session (...
Other Medicine News:Health News:Weight Watchers Announces Second Quarter 2008 Earnings Conference Call 2Health News:VA Vet Centers Coming to 39 Communities 2Health News:Statement of the Leapfrog Group on Hospital Overdose of Up to 17 Babies at CHRISTUS Spohn 2Health News:New Technique Harvests Stem Cells at Earlier Stage 2Health News:New Technique Harvests Stem Cells at Earlier Stage 3Health News:Human Factors Journal celebrates 50 years 2
(Date:11/9/2009)...tCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: AR...d quarter ended September 30, 2009. ,, Arena re...olders in the third quarter of 2009 of $34.8 milli...ocable to common stockholders in the third quarter... a net loss allocable to common stockholders in th...
(Date:11/9/2009)...riGene Technologies, Inc. today announced Royal In...RIFY Tagged Antigen(TM) (Over-expression Lysates) ...s funded by the Knut and Alice Wallenberg Foundati...tematically using Antibody-Based Proteomics. "Gene...high throughput manner is critical for the success...
(Date:11/9/2009)...- Asthmatx, Inc. presented the results of a series...fety of bronchial thermoplasty delivered by the Al...impact allergy practices, this past weekend in a p...ollege of Allergy, Asthma and Immunology (ACAAI), ...re Could Bronchial Thermoplasty (BT) Fit Into Your...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 1AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 1Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 3Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 4
... Lixte,Biotechnology Holdings, Inc. (OTC Bulletin ...rom each of two different types of drugs being,dev...f brain cancers have,activity against human pancre...h, President and CEO of Lixte, said, "Lixte previo... different classes of,pharmacologic agents have si...
...eting with the FDA for the Fabry Program and Init...lights for the Quar...(Nasdaq: FOLD ), a biopharmaceutical company deve...logical chaperones for the treatment of human,gene...r the second quarter,of 2008. On a reported basis ...
Other Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2Amicus Therapeutics Announces Second Quarter 2008 Financial Results 2Amicus Therapeutics Announces Second Quarter 2008 Financial Results 3Amicus Therapeutics Announces Second Quarter 2008 Financial Results 4Amicus Therapeutics Announces Second Quarter 2008 Financial Results 5Amicus Therapeutics Announces Second Quarter 2008 Financial Results 6Amicus Therapeutics Announces Second Quarter 2008 Financial Results 7Amicus Therapeutics Announces Second Quarter 2008 Financial Results 8Amicus Therapeutics Announces Second Quarter 2008 Financial Results 9Amicus Therapeutics Announces Second Quarter 2008 Financial Results 10Amicus Therapeutics Announces Second Quarter 2008 Financial Results 11Amicus Therapeutics Announces Second Quarter 2008 Financial Results 12
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: